From Ideas to Impact: Emerging Health Technologies in Action

1 – 2 Jun 2026 | Brussels, Belgium

Home Participants Agenda Project cooperation Pitching details Contact WIDERA GRANTS

Participants - All

Participant search result

12 participants found

Sieć Badawcza Łukasiewicz - PORT

R&D Institution • Wrocław, Poland •

3 members

Coordinator of Industry Contact Point Medical Technologies and Health
Horizon Europe Specialist
Immunotherapy Group Leader

EIT Health

Public Authority/Government • Munich, Germany •

1 member

Ecosystem Manager East

Łukasiewicz Research Network - Institute for Sustainable Technologies

R&D Institution • Radom, Poland •

2 members

Head of the Hybrid Learning and Behavioural Economics Centre
Scientific Researcher

Health Policy Institute NGO

Other • Gdańsk, Poland •

1 member

Chairwoman of the Board

Medical University of Gdańsk

University • Gdańsk, Poland •

1 member

PROJECT MANAGER

Medical University of Lodz

University • Lodz, Poland •

1 member

Deputy Director, Projects and Strategy Service Centre

Grants8

Start-up • Rzeszow, Poland •

1 member

CEO & Co-Founder

C

Crido Business & Innovation Consulting

Freelancer/Consulting • Warszawa, Poland •

1 member

Senior Manager

MŚP

Company (SME) • Warszawa, Poland •

1 member

Prezes i dyrektor projektu

12 results

Search participants

Countries

Poland (12)

Spain (9)

Georgia (6)

Belgium (5)

Greece (4)

Türkiye (3)

Italy (2)

Romania (2)

Slovakia (2)

France (2)

Ireland (1)

Austria (1)

Netherlands (1)

Sweden (1)

Thailand (1)

United Kingdom (1)

Croatia (1)

Germany (1)

Organisation Types

R&D Institution (5)

University (2)

Public Authority/Government (1)

Freelancer/Consulting (1)

Company (SME) (1)

Start-up (1)

Other (1)

Areas of Activity

Areas of Activity

Other (6)

IHI Topic 1: IHI European healthcare incubator network (3)

HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients (RIA) (3)

IHI Topic 2: An AI foundation toxicology model and framework to support waiving a second species in drug safety studies (2)

IHI Topic 3: Decode the immuno-science of age-related mediated diseases (2)

HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research (RIA) (2)

HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease (RIA) (2)

HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers (RIA) (2)

HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care (RIA) (2)

HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC) (IA) (2)

HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine (RIA) (2)

HORIZON_MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment (2)

HORIZON_MISS-2027-02-CANCER-02 Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers (2)

HORIZON_MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes (2)

HORIZON_MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research (2)

HORIZON_MISS-2027-02-CANCER-06 Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agencies (2)

HORIZON_MISS-2027-02-CANCER-05 Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines (1)

Footer navigation

Powered by b2match

Terms of Use
Privacy Policy
Imprint

Powered by b2match